ZEVRA THERAPEUTICS, INC. (ZVRA) › Cost of RevenueZEVRA THERAPEUTICS, INC. (ZVRA) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2021: $2.06M2022: $222.0K2023: $2.94M$2.94M2021Cost of Revenue (USD)2023Fiscal YearCost of RevenueChange YoY2023$2.94M+1226.6%2022$222.0K-89.2%2021$2.06M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share